Drug Database
Back to search

Czechia· CZ-0118656

NALBUPHIN ORPHA

A nalbuphine product containing nalbuphine hydrochloride, registered in Czechia by Orpha-Devel Handels und Vertriebs GmbH, Purkersdorf. The same ATC class is registered in 11 of our 19 countries.

ATC N02AF02

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedNALBUPHIN ORPHAATCN02AF02REGISTER NO.CZ-0118656PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about nalbuphine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Nalbuphine is registered in 11 of 19 countries.

Countries holding a registration under ATC N02AF02 (nalbuphine), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose
Search nalbuphine products by name

Nalbuphine · ATC N02AF02

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
NALBUPHINE HYDROCHLORIDE
Manufacturer
Orpha-Devel Handels und Vertriebs GmbH, Purkersdorf
Country
Czechia (CZ)
ATC code
N02AF02
ATC class
Nalbuphine
Defined daily dose
80 mg, P
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 1

1 priced
  • cz_kod_sukl
    0118656
    10X2ML
    CZK 854

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

148 interactions on record for nalbuphine.

Graded by severity as the source publishes them — 18 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check nalbuphine against other medicinesHow interaction checks work

Nalbuphine · interactions on record

148 records

  • 18 severe
  • 98 moderate
  • 32 info

Most severe, free to view

  • AlvimopanA06AH02severe
  • OpiumA07DA02severe
  • ChlorphenesinD01AE07severe
  • ChlorphenesinG01AX21severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nalbuphine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nalbuphine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Nalbuphin Amomed, Nubain
  • Germany · Nalpain, Nubain
  • France · Nalbuphine Renaudin, Nalbuphine Serb
  • Greece · Nalpain
  • Hungary · Nalpain
  • Netherlands · Nalbufine Hcl Orpha
  • Poland · Nalpain

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e0e8e75d-aad1-4a1f-8b04-9ed6edbd69cf
GET /v1/drugs/e0e8e75d-aad1-4a1f-8b04-9ed6edbd69cf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ SOL",
  "source": "sukl",
  "strength": "10MG/ML",
  "pack_size": "10X2ML",
  "substance": "NALBUPHINE HYDROCHLORIDE",
  "cz_kod_sukl": "0118656",
  "product_type": "CH",
  "substance_codes": "9701",
  "registration_state": "R",
  "registration_number": "65/622/07-C"
}
API referenceMCP serverPlans

See everything about nalbuphine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console